C7A.00
Malignant carcinoid tumor of unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
A malignant carcinoid tumor is a type of cancer that develops from neuroendocrine cells, which are specialized cells capable of producing hormones. When the precise location of the tumor cannot be distinguished or specified, it is classified as a malignant carcinoid tumor of an unspecified site under ICD-10 code C7A.00. These tumors can occur in various parts of the body, including the gastrointestinal tract and lungs, and may vary in behavior and severity. Recognizing the nature of carcinoid tumors is essential because their presentation and treatment can significantly differ from other types of cancers.
Causes & Symptoms
Clinical Causes: Genetic factors that influence cell growth Family history of neuroendocrine tumors Environmental exposures, although these are less well-defined Certain inherited syndromes that predispose individuals to neuroendocrine tumors
Key Symptoms: Flushing episodes, often during a carcinoid crisis Abdominal pain or discomfort Diarrhea or changes in bowel habits Unexplained weight loss Facial swelling or redness Respiratory symptoms such as cough or wheezing, if tumors are in the lungs Fatigue and general weakness Apparent tumor mass or swelling in affected areas
Diagnostic & Treatment
Diagnosis Path: Imaging tests such as computed tomography (CT) scans, magnetic resonance imaging (MRI), or somatostatin receptor scintigraphy (OctreoScan) Laboratory tests including measurement of serotonin or its metabolites like 5-HIAA in blood or urine Biopsy of the suspected tumor tissue for histopathological analysis Endoscopic procedures to visualize internal sites and obtain tissue samples
Treatment Protocols: Surgical removal of the tumor, which may involve partial or complete resection of the affected organ Medications such as somatostatin analogs (e.g., octreotide) to control hormone-related symptoms and inhibit tumor growth Chemotherapy in cases where the tumor has spread or is unresectable Targeted therapies and peptide receptor radionuclide therapy (PRRT) for advanced cases Supportive care to manage symptoms and improve quality of life
Clinical Advice & FAQs
Billing Guidance
Is C7A.00 a billable ICD-10 code?
Yes, C7A.00 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C7A.00?
Clinical documentation must specify the nature of Malignant carcinoid tumor of unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference